Application Note: Covid-19 ELISA Assays by Biorbyt
13 January 2022

Biorbyt and Daresbury Proteins are excited to announce the launch of novel Covid-19 IgG and IgM ELISA assays, providing sensitive and reliable measurements of specific antibodies as a result of Covid-19 infections and vaccination programs. Download this application notes to find out the advantages of using these novel assays and how they edge alternative antibody assays

Company